Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 106
Filtrar
1.
Eur J Pharmacol ; 325(2-3): 165-72, 1997 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-9163563

RESUMEN

Acetate, derived from ethanol metabolism in the liver, is released into the circulation and utilized in many tissues including the brain. The subsequent metabolism of acetate results in the production of adenosine that has a number of effects in the central nervous system. The purpose of the present studies, therefore, was to investigate the contribution of metabolically generated adenosine to the ethanol-induced potentiation of the inhalational agents isoflurane and sevoflurane. Changes in the anesthetic requirement for isoflurane and sevoflurane were determined in rats using the tail-clamp procedure. Both ethanol and sodium acetate reduced anesthetic requirement for isoflurane and sevoflurane in a dose-dependent fashion. The effect of acetate on anesthetic requirement was completely blocked by the administration of the adenosine receptor blocker, 8-phenyltheophylline. The ethanol-induced reduction in anesthetic requirement, however, was only partially blocked by 8-phenyltheophylline. Direct intracerebroventricular (i.c.v.) administration of the water-soluble adenosine receptor blocker, 8-sulfophenyltheophylline, also completely blocked the effect of acetate and partially blocked the effect of ethanol. This i.c.v. administration demonstrates that the actions of ethanol and acetate on anesthetic requirement are a central nervous system effect. The i.c.v. administration of the adenosine A1 receptor subtype agonist, R-phenylisopropyl adenosine, potentiated the anesthetic effects of isoflurane and suggests that the A receptor mediates the observed potentiation of anesthetic effect. This is further supported by the concomitant administration of 5-N-ethylcarboxamido adenosine, a non-selective adenosine agonist, with the selective A1 antagonist, 8-cyclopentyltheophylline, showing A1 receptor potentiation of anesthetic requirements. The studies show that (1) acetate potentiates the anesthetic effects of the inhalational anesthetics, sevoflurane and isoflurane; (2) acetate contributes in part to the effect of ethanol on anesthetic potency through metabolically generated adenosine; (3) these effects are likely mediated via adenosine A1 receptor subtypes.


Asunto(s)
Adenosina/fisiología , Anestésicos por Inhalación/administración & dosificación , Etanol/administración & dosificación , Éteres Metílicos , Ácido Acético/metabolismo , Adenosina/administración & dosificación , Anestésicos por Inhalación/farmacocinética , Animales , Sinergismo Farmacológico , Éteres/administración & dosificación , Éteres/farmacocinética , Isoflurano/administración & dosificación , Isoflurano/farmacocinética , Masculino , Alveolos Pulmonares/efectos de los fármacos , Alveolos Pulmonares/metabolismo , Antagonistas de Receptores Purinérgicos P1 , Ratas , Ratas Sprague-Dawley , Sevoflurano , Teofilina/administración & dosificación , Teofilina/análogos & derivados
2.
J Hepatol ; 20(3): 343-9, 1994 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-8014444

RESUMEN

Although propylthiouracil has previously been shown to reduce the risk of mortality in alcoholic liver disease by 60%, generalized use of propylthiouracil for this condition has not occurred. Additional data are therefore presented on four aspects to provide a better assessment of its therapeutic effectiveness. First, the characteristics and the prognosis of dropouts were virtually identical in both the drug and placebo groups. Also the methodology and analysis employed, were designed to control for dropouts, thus providing an accurate interpretation of the outcome. Secondly, since 97% of the patients continued to drink, abstinence was not a precondition for the beneficial effect of propylthiouracil. However, the beneficial effect was observed most clearly in those patients who continued to drink at lower levels, whereas lower level drinking per se did not afford protection in placebo patients. Thirdly, serious side effects or clinical hypothyroidism occurred extremely rarely in these patients, many of whom have now received propylthiouracil for over 4 years. Fourthly, we discuss why the outcome in long-term clinical trials in alcoholic liver disease cannot be compared with effects observed in clinical trials lasting only a few weeks. Journal of Hepatology.


Asunto(s)
Hepatopatías Alcohólicas/tratamiento farmacológico , Propiltiouracilo/uso terapéutico , Ensayos Clínicos como Asunto , Femenino , Estudios de Seguimiento , Humanos , Hipotiroidismo/inducido químicamente , Hepatopatías Alcohólicas/epidemiología , Hepatopatías Alcohólicas/mortalidad , Masculino , Persona de Mediana Edad , Cooperación del Paciente , Propiltiouracilo/efectos adversos , Factores de Tiempo
3.
Alcohol Clin Exp Res ; 18(1): 144-8, 1994 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8198211

RESUMEN

Ethanol has been shown to increase markedly portal blood flow, primarily by increasing intestinal blood flow. This effect of ethanol is reproduced by acetate, infused at rates equivalent to those leading to endogenous acetate production following ethanol administration. The physiological mediator, adenosine, is also known to increase markedly intestinal and portal tributary blood flow. We have shown that adenosine receptor blockade with 8-phenyltheophylline completely abolishes the effects of ethanol, acetate, and adenosine on intestinal and portal blood flow, suggesting that increases in adenosine tone may constitute a common mechanism mediating the actions of both ethanol and acetate on the splanchnic vasculature. Studies are also presented that show that acetate administration has marked effects on central nervous system function. On two tests, motor coordination and anesthetic potency, both ethanol and acetate showed similar effects. The effects of acetate were fully abolished by 8-phenyltheophylline. The effects of ethanol were partially blocked by 8-phenyltheophylline, with a greater effect of this blocker being seen at low doses of alcohol. Whereas ethanol at low doses increased locomotor activity in mice, acetate markedly reduced it. The effect of acetate on locomotion was fully reversed by the adenosine receptor blocker 8-phenyltheophylline, whereas the activating effect of ethanol on locomotion was markedly enhanced by this blocker. These data suggest that the actions of ethanol on locomotor activity normally result from the combination of a direct stimulatory effect of ethanol per se and an inhibitory effect of acetate, produced endogenously from ethanol. When the latter effect of acetate is abolished by adenosine receptor blockade, the activating effect of ethanol is fully expressed.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Acetaldehído/toxicidad , Acetatos/toxicidad , Alcoholismo/fisiopatología , Etanol/toxicidad , Acetaldehído/farmacocinética , Acetatos/farmacocinética , Animales , Encéfalo/efectos de los fármacos , Encéfalo/fisiopatología , Relación Dosis-Respuesta a Droga , Metabolismo Energético/efectos de los fármacos , Metabolismo Energético/fisiología , Etanol/farmacocinética , Humanos , Circulación Esplácnica/efectos de los fármacos , Circulación Esplácnica/fisiología
4.
Anesthesiology ; 80(1): 159-67, 1994 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-8291705

RESUMEN

BACKGROUND: It has been suggested that the liver may be at risk for ischemic damage during adenosine-induced hypotension. This notion, however, is somewhat inconsistent with the understanding that adenosine is a powerful vasodilator of the splanchnic circulation. To help clarify the effect of adenosine-induced hypotension on splanchnic hemodynamics, we studied the systemic and splanchnic hemodynamic responses to adenosine, both alone and in the presence of halothane or sevoflurane. METHODS: Systemic and splanchnic hemodynamics were determined during the infusion of adenosine in 36 rats allocated randomly to one of three study groups: (1) awake, (2) halothane anesthesia (1.0 MAC), or (3) sevoflurane anesthesia (1.0 MAC). Adenosine was infused at a rate sufficient to decrease the mean arterial pressure by 35-38% from awake control values. Cardiac output and organ blood flows were measured using the radiolabeled microsphere technique. RESULTS: Adenosine infusion produced stable hypotension of rapid onset due to a reduction in systemic vascular resistance. Stroke volume increased, but cardiac output remained unchanged in the awake and sevoflurane groups because of a decrease in heart rate. Infusion of adenosine during halothane anesthesia increased cardiac output enough to compensate for the decrease in cardiac output due to halothane alone. In the splanchnic circulation, there was an increase in portal tributary (42%, P < 0.01) and hepatic arterial (38%, P < 0.05) blood flows during adenosine infusion in awake rats. This resulted in an overall increase in total liver blood flow (42%, P < 0.01). Halothane anesthesia was associated with a decrease in portal tributary blood flow (28%, P < 0.05). In contrast, sevoflurane anesthesia was associated with an increase in hepatic arterial flow (35%, P < 0.05) but with no change in portal tributary blood flow. During halothane anesthesia, adenosine infusion increased portal tributary (90%, P < 0.01) and hepatic arterial (37%, P < 0.05) blood flows, thereby increasing total liver blood flow to values similar to those in awake adenosine-infused rats. During sevoflurane anesthesia, adenosine infusion increased portal tributary blood flow (48%, P < 0.01), but hepatic arterial blood flow did not increase beyond the values observed during sevoflurane anesthesia alone. CONCLUSIONS: These findings demonstrate that adenosine is a potent vasodilator of portal tributary and hepatic arterial vasculature in the rat and that the splanchnic hemodynamic effects of adenosine predominate over those of halothane and sevoflurane.


Asunto(s)
Adenosina/farmacología , Anestesia por Inhalación , Anestésicos , Éteres , Halotano , Hemodinámica/efectos de los fármacos , Hipotensión Controlada , Éteres Metílicos , Animales , Hemodinámica/fisiología , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Sevoflurano , Circulación Esplácnica/fisiología
5.
Hepatology ; 18(2): 415-21, 1993 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8340071

RESUMEN

It has been postulated that the beneficial effects of the antithyroid drug propylthiouracil in the treatment of alcoholic liver disease depend primarily on the action of propylthiouracil in suppressing the increase in hepatic oxygen consumption induced by ethanol. The evidence for this effect of propylthiouracil is derived from studies in which liver oxygen consumption has been determined in in vitro preparations. In our study the effects of ethanol and propylthiouracil on liver oxygen consumption were assessed in vivo in an unrestrained and unanesthetized rat model, where liver blood flow and hepatic vein and portal vein oxygen content can be measured. Data show that the liver oxygen consumption increased in rats treated with ethanol-containing liquid diets for 4 to 6 wk, both on withdrawal of alcohol (30%, p < 0.01), and after readministration of ethanol (50%, p < 0.01). Single-dose ethanol administration increased portal tributary blood flow without affecting hepatic arterial blood flow in both controls and rats withdrawn from long-term ethanol treatment. Long-term ethanol administration per se had no effect on portal tributary blood flow; however, hepatic arterial blood flow was increased by 38% (p < 0.01). Treatment with propylthiouracil for 5 days resulted in complete suppression of the increase in liver oxygen consumption induced by long-term ethanol administration. Propylthiouracil treatment also attenuated the increase in portal tributary blood flow after the administration of a single dose of ethanol. These determinations were made 24 hr after the last dose of propylthiouracil.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Etanol/farmacología , Hígado/metabolismo , Consumo de Oxígeno/efectos de los fármacos , Propiltiouracilo/farmacología , Animales , Hemodinámica/efectos de los fármacos , Circulación Hepática/efectos de los fármacos , Masculino , Oxígeno/sangre , Sistema Porta/efectos de los fármacos , Propiltiouracilo/administración & dosificación , Ratas , Ratas Sprague-Dawley , Circulación Esplácnica/efectos de los fármacos , Factores de Tiempo , Vigilia
7.
Alcohol Alcohol Suppl ; 2: 411-8, 1993.
Artículo en Inglés | MEDLINE | ID: mdl-7748331

RESUMEN

Ethanol administration leads to a marked increase in hepatic blood flow, resulting from an increase in mesenteric blood flow. Studies presented indicate that the increase in portal blood flow induced by ethanol is mediated by acetate. Acetate infusion at rates which achieve blood concentrations equal to those following ethanol administration, fully reproduce this effect of ethanol. The adenosine receptor blocker 8-phenyltheophilline (8PT) fully abolishes the increase in portal blood flow induced by both ethanol and acetate. We have proposed that the extrahepatic metabolism of acetate into acetyl-CoA yields AMP and adenosine. Studies also indicate that adenosine receptor activation has a major contribution to the CNS depressant effects of ethanol at low concentrations of ethanol (below 1.5 g/kg) where the production of acetate is near maximal and the physico-chemical effects of ethanol are minor. Acetate significantly potentiates the CNS depressant effects of general anesthetics. Data to be presented indicate that for some behaviours, acetate through an adenosine-receptor activation potentiates the effects of ethanol while in other behavioural tests they antagonize ethanol effects.


Asunto(s)
Acetatos/farmacología , Adenosina/metabolismo , Etanol/toxicidad , Acetatos/metabolismo , Ácido Acético , Acetilcoenzima A/metabolismo , Adenosina Monofosfato/metabolismo , Animales , Circulación Hepática/efectos de los fármacos , Circulación Hepática/fisiología , Ratones , Modelos Biológicos , Actividad Motora/efectos de los fármacos , Ratas , Receptores Purinérgicos P1/efectos de los fármacos , Receptores Purinérgicos P1/fisiología , Teofilina/análogos & derivados , Teofilina/farmacología
8.
Alcohol Clin Exp Res ; 16(6): 1064-7, 1992 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-1471760

RESUMEN

We assessed the relationship of serum type I collagen propeptide concentrations with various severity indices of alcoholic liver disease, including clinical and morphological severity, the amount of alcohol consumption, and the serum levels of other components of connective tissue. The serum concentration of the carboxyterminal propeptide of type I procollagen (PICP) was measured with a new radioimmunoassay that is devoid of a crossreaction caused by type III procollagen-derived fragments. A significant correlation was found between serum PICP and the Combined Clinical and Laboratory Index (CCLI) (rs = 0.58, p < 0.001) and the Combined Morphological Index (CMI) (rs = 0.57, p < 0.01). However, PICP was elevated less frequently than serum type III collagen propeptide (PIIINP), type IV collagen or laminin, and the correlations with the latter three parameter with both the CCLI (PIIINP: rs = 0.80, type IV collagen: rs = 0.80; and laminin: rs = 0.81) or CMI (PIIINP: rs = 0.75, type IV collagen: rs = 0.72; and laminin rs = 0.61) were all stronger than that of PICP. Furthermore, although during a follow-up period of 6 months, the mild or moderately drinking patients had a significant decrease in PIIINP and the heavily drinking patients had no improvement. PICP was, however, found to improve in both the mild and heavy drinkers. These results point to differences in handling of type I and type III collagen propeptides in alcoholic liver disease. The latter appears to be a more sensitive indicator of disease severity, presence of alcoholic hepatitis, and the amount of alcohol intake.


Asunto(s)
Hepatopatías Alcohólicas/diagnóstico , Pruebas de Función Hepática , Fragmentos de Péptidos/sangre , Procolágeno/sangre , Biopsia , Colágeno/sangre , Etanol/farmacocinética , Femenino , Humanos , Laminina/sangre , Hígado/patología , Cirrosis Hepática Alcohólica/sangre , Cirrosis Hepática Alcohólica/diagnóstico , Hepatopatías Alcohólicas/sangre , Masculino , Persona de Mediana Edad , Radioinmunoensayo
9.
Biochem Biophys Res Commun ; 189(2): 749-58, 1992 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-1339280

RESUMEN

We have cloned and sequenced a full-length cDNA (1083 bp) encoding the human liver cystathionine-gamma-lyase enzyme (cystathionase). The human cystathionase sequence presented a substantial deletion of 132 bases (44 amino acids) compared to that reported for rat cystathionase, and of 135 bases (45 amino acids) compared to that reported for yeast cystathionase. After re-alignment for the missing nucleotides, the human cDNA sequence shows significant amino acid homology to that for the rat enzyme (85%) and the yeast enzyme (50%). A search for an undeleted cDNA, by the polymerase chain reaction, yielded a second clone which contained the missing 132 bases. Flanking nucleotides in the latter clone were identical to those in the cDNA clone containing the deletion. The two forms of human cystathionase deduced from the two cDNA clones may be derived from two different genes or may be splice variants.


Asunto(s)
Cistationina gamma-Liasa/genética , ADN/genética , Hígado/enzimología , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Northern Blotting , Southern Blotting , Clonación Molecular , ADN/aislamiento & purificación , Biblioteca de Genes , Humanos , Datos de Secuencia Molecular , Oligodesoxirribonucleótidos , Reacción en Cadena de la Polimerasa , ARN Mensajero/genética , ARN Mensajero/aislamiento & purificación , ARN Mensajero/metabolismo , Ratas , Saccharomyces cerevisiae/enzimología , Saccharomyces cerevisiae/genética , Eliminación de Secuencia , Homología de Secuencia de Aminoácido
10.
Can J Anaesth ; 39(3): 270-6, 1992 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-1551159

RESUMEN

To determine the systemic haemodynamic and organ blood flow responses to the administration of sevoflurane during spontaneous ventilation, heart rate, cardiac index, mean arterial pressure, arterial blood gases, and blood flows to the brain, spinal cord, heart, kidneys and splanchnic organs were measured awake (control values) and after 30 min of anaesthesia with 0.5, 1.0, 1.2 or 1.5 MAC sevoflurane in rats. Cardiac output and organ blood flows were measured using radiolabelled microspheres. The MAC (mean +/- SEM) of sevoflurane was found to be 2.30 +/- 0.05%. At each concentration, haemodynamic variables were similar to awake values with the exception of a 12% reduction in mean arterial pressure at 1.5 MAC (P less than 0.01). Arterial PCO2 increased in a dose-related fashion. Cerebral and spinal cord blood flows increased at 1.2 and 1.5 MAC whereas coronary and renal blood flows did not change significantly. Portal tributary blood flow and preportal vascular resistance were unaffected. Hepatic arterial flow increased by 63% at 1.5 MAC (P less than 0.05) but total liver blood flow remained unchanged compared with awake values. In conclusion, the administration of sevoflurane during spontaneous ventilation produces a high degree of cardiovascular stability and maintains blood flow to major organs in the rat.


Asunto(s)
Anestesia por Inhalación , Anestésicos/farmacología , Circulación Sanguínea/efectos de los fármacos , Éteres/farmacología , Hemodinámica/efectos de los fármacos , Éteres Metílicos , Anestésicos/administración & dosificación , Animales , Presión Sanguínea/efectos de los fármacos , Dióxido de Carbono/sangre , Gasto Cardíaco/efectos de los fármacos , Circulación Cerebrovascular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Éteres/administración & dosificación , Frecuencia Cardíaca/efectos de los fármacos , Circulación Hepática/efectos de los fármacos , Alveolos Pulmonares , Circulación Pulmonar/efectos de los fármacos , Ratas , Ratas Endogámicas , Flujo Sanguíneo Regional/efectos de los fármacos , Respiración , Sevoflurano , Médula Espinal/irrigación sanguínea , Volumen Sistólico/efectos de los fármacos , Resistencia Vascular/efectos de los fármacos
12.
J Pharmacol Exp Ther ; 259(1): 403-8, 1991 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-1920128

RESUMEN

Acetate, resulting from ethanol metabolism in the liver, is released into the circulation and is utilized in a number of tissues, including the brain. In its metabolism, acetate leads to the production of adenosine, a powerful physiological mediator. We have investigated the effect of acetate on central nervous system (CNS) function in rodents. Sodium acetate in doses resulting in blood concentrations comparable to those attained after the administration of 1 to 2 g/kg ethanol, had significant CNS effects. Both ethanol and acetate produced a dose-dependent impairment of motor coordination. This effect of acetate was fully blocked by the adenosine receptor blocker 8-phenyltheophylline (8PT), whereas the dose-response relationship for ethanol was shifted to the right by about 30%. The inspired concentration of sevoflurane to achieve anesthesia was significantly reduced by both these agents. General anesthesia was potentiated in a dose-dependent fashion by ethanol and by acetate. The effect of acetate on anesthetic requirements was fully blocked by 8PT. The effect of ethanol on sevoflurane anesthetic requirements was inhibited by 22 to 35% by 8PT. Locomotor activity in mice was reduced by acetate in a dose-dependent fashion, an effect that was also fully blocked by 8PT. On the other hand, ethanol at a dose of 1 to 2 g/kg increased locomotor activity. This likely results from a direct stimulatory effect of ethanol, opposed by an inhibitor effect of acetate. The administration of 8PT enhanced the stimulation of locomotor activity induced by ethanol. In conclusion, acetate, a product of ethanol metabolism has significant CNS effects that can either potentiate or antagonize the effects of the ethanol molecule per se.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Acetatos/farmacología , Sistema Nervioso Central/efectos de los fármacos , Etanol/farmacología , Acetatos/sangre , Ácido Acético , Animales , Sistema Nervioso Central/fisiología , Interacciones Farmacológicas , Etanol/sangre , Inyecciones Intraperitoneales , Locomoción/efectos de los fármacos , Masculino , Ratones , Desempeño Psicomotor/efectos de los fármacos , Ratas , Teofilina/análogos & derivados , Teofilina/farmacología
13.
Alcohol Clin Exp Res ; 15(3): 433-7, 1991 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-1877730

RESUMEN

While some morbidities associated with the excessive use of alcohol are related to the total amount of alcohol consumed--cirrhosis being an example--other pathologies, such as trauma and those of psycho-social origin, are mainly related to the frequency of acute alcoholic intoxication rather than to the total amount consumed. The balance between these two types of alcohol-associated morbidities can provide an indication of the relative frequency of intoxication, and thus of the pattern of alcohol abuse in a population. Since trauma is highly associated with acute alcoholic intoxication, the prevalence of bone fractures was determined in cirrhotics in nine countries. The prevalence of rib and vertebral fractures on routine chest x-rays showed a 17-fold variation in the different countries, from 2% and 6% in Spain and Italy to 30% and 34% in Canada and the USA, suggesting marked differences in the pattern of alcohol abuse to intoxication. Conversely, the prevalence of cirrhosis is twice as high in Spain and Italy than in Canada and the USA. A strong positive correlation between per capita consumption and cirrhosis mortality (r = 0.86; p less than 0.01) exists among the nine countries studied, while the correlation between per capita alcohol consumption and the prevalence of trauma is not statistically significant (r = 0.40). Supporting a strong association between trauma and alcoholic intoxication, the prevalence of trauma was found to be highly correlated: r = 0.88, p less than 0.002, with the degree of concern for the psycho-social consequences of alcohol abuse in the different countries. Data indicate that trauma can be used as an objective indicator to assess the pattern of alcohol abuse in a population.


Asunto(s)
Consumo de Bebidas Alcohólicas/epidemiología , Intoxicación Alcohólica/complicaciones , Alcoholismo/epidemiología , Comparación Transcultural , Fracturas Óseas/epidemiología , Consumo de Bebidas Alcohólicas/efectos adversos , Intoxicación Alcohólica/etiología , Alcoholismo/complicaciones , Estudios Transversales , Fracturas Óseas/etiología , Humanos , Incidencia , Persona de Mediana Edad , Fracturas de las Costillas/epidemiología , Fracturas de las Costillas/etiología , Problemas Sociales/estadística & datos numéricos , Traumatismos Vertebrales/epidemiología , Traumatismos Vertebrales/etiología
14.
Alcohol Alcohol Suppl ; 1: 351-5, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1845562

RESUMEN

We have examined the relationship between blood markers of fibrogenesis and basement membrane formation and alcohol intake in patients with a wide range of clinical and histological severity of alcoholic liver disease (Niemelä et al., 1990). While the patients with a mean of less than 8 mM alcohol in morning urines (mild or moderate drinkers) had a significant (p < 0.00001) decrease in serum aminoterminal propeptide of type III procollagen, type IV collagen and laminin in a period of 27 +/- 1 weeks, the patients with more than 8 mM of urinary alcohol (heavy drinkers) had no improvement. There was also a significant decrease in serum gamma glutamyl transferase activity in the group with lower, but not in that with the higher urinary alcohol concentrations. The Combined Clinical and Laboratory Index (CCLI) decreased in both groups, although the recovery was significantly (p < 0.03) greater in those with the lower urinary alcohol levels (66% +/- 6%) than in the group with a urinary alcohol level of > or = 8 mM (28% +/- 15%). We suggest that connective tissue metabolism in alcoholic liver disease is closely related to alcohol intake and thus affects the prognosis of the alcoholic patient.


Asunto(s)
Consumo de Bebidas Alcohólicas/metabolismo , Tejido Conectivo/metabolismo , Cirrosis Hepática Alcohólica/metabolismo , Hepatopatías Alcohólicas/metabolismo , Biomarcadores/sangre , Colágeno/sangre , Femenino , Humanos , Cirrosis Hepática Alcohólica/tratamiento farmacológico , Hepatopatías Alcohólicas/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Fragmentos de Péptidos/sangre , Procolágeno/sangre , Riboflavina/uso terapéutico
15.
Clin Chem ; 37(1): 5-13, 1991 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-1988208

RESUMEN

Monitoring the effectiveness of treatment sfor alcoholic liver disease involves the use of variables that have prognostic significance and are unaffected by the treatment in unspecific ways. Here we review the value of histological and functional variables for this purpose. We conclude that histological variables, although important in defining the characteristics of the sample, have several practical problems. The functional variables are most effective when used in combinations, e.g., in global indices such as the Combined Clinical and Laboratory Index, the Child-Turcotte-Pugh Index, or the Cox model. In situations involving mortality and dropouts, functional indices cannot be used to measure changes in severity; in such cases, mortality might be the only measure for assessing the effectiveness of a treatment. In clinical trials, it is essential to determine the risk of a Type II error, to monitor compliance and drinking, and to trace appropriately all the patients who were not compliant or who dropped out of the trial.


Asunto(s)
Hepatopatías Alcohólicas/terapia , Humanos , Hígado/patología , Hígado/fisiopatología , Hepatopatías Alcohólicas/mortalidad , Hepatopatías Alcohólicas/patología , Hepatopatías Alcohólicas/fisiopatología , Pronóstico
16.
Am J Physiol ; 259(6 Pt 1): G1010-8, 1990 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-2260656

RESUMEN

The relationship between portal tributary blood flow (PBF) and hepatic arterial blood flow (HAF) was studied in awake, unrestrained rats with the radiolabeled microsphere technique. Six distinct patterns of response emerged. In group A (PBF+, HAF 0), ethanol, acetate, glucagon, prostacyclin, and a mixed diet increased PBF without a change in HAF; in group B (PBF+, HAF+), adenosine and histamine increased both PBF and HAF; in group C (PBF 0, HAF+), isoflurane and triiodothyronine did not change PBF but increased HAF; and in group D (PBF-, HAF+), halothane and vasopressin decreased PBF and increased HAF. Acute partial portal vein ligation decreased PBF (56%) and increased HAF (436%). Hypoxia (7.5% O2) decreased PBF (28%) and increased HAF (110%). In group E (PBF+, HAF-), acute hepatic artery ligation increased PBF (35%) and reduced HAF (74%), while in group F (PBF-, HAF-), thyroidectomy reduced PBF and HAF (36 and 47%, respectively). All blood flow responses were accompanied by the expected changes in both portal tributary and hepatic arterial vascular resistances. The data suggest that the portal and hepatic arterial vascular territories have regulatory mechanisms that allow for independent changes.


Asunto(s)
Arteria Hepática/fisiología , Circulación Hepática , Vena Porta/fisiología , Acetatos/farmacología , Animales , Presión Sanguínea/efectos de los fármacos , Gasto Cardíaco/efectos de los fármacos , Epoprostenol/farmacología , Etanol/farmacología , Glucagón/farmacología , Circulación Hepática/efectos de los fármacos , Masculino , Microesferas , Ratas , Ratas Endogámicas , Flujo Sanguíneo Regional/efectos de los fármacos , Triyodotironina/farmacología , Resistencia Vascular/efectos de los fármacos , Vasopresinas/farmacología
19.
Gastroenterology ; 98(6): 1612-9, 1990 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-1692550

RESUMEN

This study investigated the relationships of the serum markers of fibrogenesis and basement membrane formation to the clinical and morphological severity of alcoholic liver disease and to the degree of alcohol abuse. The concentrations of the aminoterminal propeptide of type III collagen, type IV collagen, and laminin were measured from 87 samples representing a wide range of clinical and histological severities of the disease, which were assessed with indices that have been shown to correlate well with the risk of dying within 1 yr. Significant correlations (p less than 0.00001) were found between the markers of connective tissue metabolism and the Combined Clinical and Laboratory Index: (aminoterminal propeptide of type III collagen, rs = 0.82; type IV collagen, rs = 0.82; laminin, rs = 0.81), as well as between these markers and the Combined Morphological Index: (aminoterminal propeptide of type III collagen, rs = 0.70; type IV collagen, rs = 0.68; laminin, rs = 0.64). Whereas the patients with less than 8 mM of alcohol in their morning urine (mild or moderate drinkers) showed a significant (p less than 0.00001) decrease in these markers in a period of 27 +/- 1 wk, the patients with more than 8 mM of urinary alcohol (heavy drinkers) had no improvement. It is proposed that both fibrogenesis and basement membrane formation are associated with disease severity, degree of alcoholic hepatitis, and alcohol intake, which are important determinants of prognosis in alcoholic liver disease.


Asunto(s)
Consumo de Bebidas Alcohólicas , Membrana Basal/metabolismo , Colágeno/sangre , Hepatitis/complicaciones , Laminina/sangre , Cirrosis Hepática Alcohólica/sangre , Fragmentos de Péptidos/sangre , Procolágeno/sangre , Retículo Endoplásmico/ultraestructura , Etanol/orina , Femenino , Estudios de Seguimiento , Hepatitis/patología , Humanos , Hialina , Cirrosis Hepática Alcohólica/complicaciones , Cirrosis Hepática Alcohólica/patología , Cirrosis Hepática Alcohólica/fisiopatología , Cirrosis Hepática Alcohólica/orina , Masculino , Persona de Mediana Edad , Pronóstico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA